![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_85ccd46fda01e8deeca3cd581604f4c6.svg) | (1R,2S,5R,8S,9R,17R,18R,21S,24R,26S,27S)-5-Hydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.118,27.01,5.02,24.08,17.09,14.021,26]nonacosa-11,14-diene-4,10,22,29-tetrone | IC50 | 37500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_3559638156f5457b2d3ac020ff63b826.svg) | 5,6-Epxoyphysalin B | IC50 | 27100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_32133b647776a507698a387b566b851d.svg) | Physalin A | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_16b72820a74247520b8a1c2ed44d9e6d.svg) | Withanolide E | IC50 | 18000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_6effe1ce7ecdcde55ca88f49f6783963.svg) | (2R)-2-[(1S)-1-[(8R,9S,10R,13S,14R,17S)-14,17-Dihydroxy-10,13-dimethyl-1-oxo-4,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-1-hydroxyethyl]-4,5-dimethyl-2,3-dihydropyran-6-one | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_5ca18d822a569b2fe6f5ddd1cd4277b4.svg) | (1S,2S,3R,5R,6S,7R,14R,15S,18R,21S,22R,25S)-5,7,18-Trihydroxy-1,14,21,25-tetramethyl-4,20,23-trioxaheptacyclo[20.3.1.12,5.03,18.03,21.06,15.09,14]heptacosa-8,11-diene-13,19,24,27-tetrone | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_c306b9e06ae088c3d0acae3a85164487.svg) | (2R)-2-[(1R)-1-Hydroxy-1-[(8R,9S,10R,13R,14R,17S)-14-hydroxy-10,13-dimethyl-1-oxo-7,8,9,11,12,15,16,17-octahydro-4H-cyclopenta[a]phenanthren-17-yl]ethyl]-4,5-dimethyl-2,3-dihydropyran-6-one | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_59f6e11224f39951ba82efe69435a469.svg) | Physalin J | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_643472780200d31760a616359d52847d.svg) | (2R)-2-[(1R)-1-Hydroxy-1-[(8R,9S,10R,13R,14R)-14-hydroxy-10,13-dimethyl-1-oxo-7,8,9,11,12,15-hexahydro-4H-cyclopenta[a]phenanthren-17-yl]ethyl]-4,5-dimethyl-2,3-dihydropyran-6-one | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_47cdd199fb99e62744036416ec101fa7.svg) | (3R,4S)-4-[(2R,3S)-3-[(8R,9S,10R,13S,14R,17S)-14,17-Dihydroxy-10,13-dimethyl-1-oxo-4,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2,3-dihydroxybutyl]-3-methyloxolan-2-one | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_c5737ff42604741c466422ba8863a02d.svg) | (3R,4S)-4-[(2R,3S)-3-[(8R,9S,10R,13S,14R,17R)-14,17-Dihydroxy-10,13-dimethyl-1-oxo-4,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2,3-dihydroxybutyl]-3-methyloxolan-2-one | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_c212861018dc3cddcceae62bd6150a1c.svg) | 25-Hydroxy physalin J | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_8e3e33c5237ed58f87e078da23d3e759.svg) | (1S,2S,3R,5R,6R,14R,15S,18R,21S,22R)-5,18-Dihydroxy-1,14,21-trimethyl-25-methylidene-4,20,23-trioxaheptacyclo[20.3.1.12,5.03,18.03,21.06,15.09,14]heptacosa-8,11-diene-13,19,24,27-tetrone | IC50 | 26200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_87e725fed3ad4907f1583e1e6f803133.svg) | (1R,2S,5S,8S,9R,16R,17S,18R,21S,24R,26S,27S)-5,16-Dihydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.118,27.01,5.02,24.08,17.09,14.021,26]nonacosa-11,14-diene-4,10,22,29-tetrone | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_e772c1fb07d52ec8b86e64371c0b8cc3.svg) | 25-Hydroxy physalin F | IC50 | 30100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nf-kappab-inhibitor-alpha_1d23bd446a211160066696627c7feabc.svg) | (1S,2S,3R,5R,6R,14R,15S,18R,21S,22R,25S)-5,18,25-Trihydroxy-1,14,21,25-tetramethyl-4,20,23-trioxaheptacyclo[20.3.1.12,5.03,18.03,21.06,15.09,14]heptacosa-8,11-diene-13,19,24,27-tetrone | IC50 | 50000.0 [1] |